tiprankstipranks
Syntara Limited’s SNT-5505 Shows Promise in Myelofibrosis Trial
PremiumCompany AnnouncementsSyntara Limited’s SNT-5505 Shows Promise in Myelofibrosis Trial
1M ago
Syntara Prepares to Unveil Promising Myelofibrosis Data
Premium
Company Announcements
Syntara Prepares to Unveil Promising Myelofibrosis Data
1M ago
Syntara Limited Prepares for Interim Trial Data Release
Premium
Company Announcements
Syntara Limited Prepares for Interim Trial Data Release
2M ago
Syntara Limited to Present Promising Cancer Trial Results
PremiumCompany AnnouncementsSyntara Limited to Present Promising Cancer Trial Results
2M ago
Pharmaxis Ltd Highlights Product Pipeline and Risks
Premium
Company Announcements
Pharmaxis Ltd Highlights Product Pipeline and Risks
3M ago
Syntara Limited Advances Drug Trials and Financial Strategy
Premium
Company Announcements
Syntara Limited Advances Drug Trials and Financial Strategy
3M ago
Pharmaxis Ltd Reports Significant Shareholding Change
PremiumCompany AnnouncementsPharmaxis Ltd Reports Significant Shareholding Change
3M ago
Pharmaxis Ltd Faces Uncertain Future in Product Development
Premium
Company Announcements
Pharmaxis Ltd Faces Uncertain Future in Product Development
3M ago
Syntara Limited Director Boosts Stake
Premium
Company Announcements
Syntara Limited Director Boosts Stake
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100